Samy Badawy
Wyndmoor, PANPI 1578625497
Payments from drug & device makers
$2,503in general payments, 2019–2025
Across 137 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$767
- Johnson & Johnson$630
- Sun Pharmaceutical Industries Inc.$212
- Regeneron Healthcare Solutions, Inc.$205
- Genentech USA, Inc.$121
- Incyte Corporation$90
- plus $477 from 14 others
What the payments were for
- Food & beverage$2,503100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $767 |
| Johnson & Johnson | 37 | $630 |
| Sun Pharmaceutical Industries Inc. | 11 | $212 |
| Regeneron Healthcare Solutions, Inc. | 10 | $205 |
| Genentech USA, Inc. | 8 | $121 |
| Incyte Corporation | 4 | $90 |
| Novartis | 4 | $85 |
| LEO Pharma Inc. | 4 | $61 |
| EPI Health, LLC | 1 | $55 |
| Amgen | 3 | $51 |
| Almirall LLC | 2 | $45 |
| Lilly USA, LLC | 1 | $25 |
| Dermira, Inc. | 1 | $25 |
| Sanofi | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Sandoz | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Biofrontera Inc. | 1 | $17 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Mission Pharmacal Company | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.